High miR-198 expression decreases c-MET expression, which inhibits hepatocyte growth factor (HGF)-induced activation of ERK1/2 MAPK signaling in HCC cells, thereby inhibiting the migration and invasion of HCC cells. This evidence concerns the gene MAPK3 and hepatocellular carcinoma.